BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 3114551)

  • 1. [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].
    Niederle N; Doberauer C; Kloke O; Höffken K; Schmidt CG
    Klin Wochenschr; 1987 Jul; 65(14):706-12. PubMed ID: 3114551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.
    Ratain MJ; Golomb HM; Bardawil RG; Vardiman JW; Westbrook CA; Kaminer LS; Lembersky BC; Bitter MA; Daly K
    Blood; 1987 Mar; 69(3):872-7. PubMed ID: 3814819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
    Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
    J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
    Hasselbalch H; Braide I; Lisse I; Röckert LL; Swolin B; Carneskog J; Hagberg H; Hippe E; Jensen MK; Lundin P
    Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low-dose alpha-interferon treatment of hairy cell leukemia].
    von Wussow P; Freund M; Block B; Diedrich H; Schmoll H; Poliwoda H; Deicher H
    Klin Wochenschr; 1987 Jul; 65(14):681-4. PubMed ID: 3626433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL).
    Damasio EE; Frassoldati A
    Leuk Lymphoma; 1994; 14 Suppl 1():95-8. PubMed ID: 7820061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
    Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
    Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia].
    Kloke O; May D; Wandl U; Niederle N
    Onkologie; 1988; 11 Suppl 2():41-5. PubMed ID: 3065687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant (IFN-alpha 2b) therapy in hairy cell leukemia].
    Schwarzmeier JD; Wagner L; Prischl F; Schwabe M; Lion T; Micksche M; Köller U; Bernhart M; Fritz O; Seewann HL
    Klin Wochenschr; 1987 Jul; 65(14):699-705. PubMed ID: 3114550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
    Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
    Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
    Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
    Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia.
    Golomb HM; Ratain MJ; Fefer A; Thompson J; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Bonnem E
    J Natl Cancer Inst; 1988 May; 80(5):369-73. PubMed ID: 3282078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.
    Golomb HM; Fefer A; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Ratain MJ; Thompson J; Bonnem EM
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):13-7. PubMed ID: 3589701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha in the treatment of hairy cell leukemia.
    Castaigne S; Sigaux F; Cantell K; Falcoff E; Boiron M; Flandrin G; Degos L
    Cancer; 1986 Apr; 57(8 Suppl):1681-4. PubMed ID: 3948138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of interferon in the treatment of hairy cell leukemia.
    Ratain MJ; Vardiman JW; Golomb HM
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):21-8. PubMed ID: 3532332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
    Golomb HM; Jacobs A; Fefer A; Ozer H; Thompson J; Portlock C; Ratain M; Golde D; Vardiman J; Burke JS
    J Clin Oncol; 1986 Jun; 4(6):900-5. PubMed ID: 3519880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenectomy after initial therapy with alpha-IFN in patients with hairy-cell leukemia (HCL): a multi-center study by the Italian Cooperative Group for HCL. Preliminary results.
    Damasio EE; Federico M; Frassoldati A; Lamparelli T; Annino L; Bernasconi C; Chisesi T; Foá R; Lauria F; Pagnucco G
    Eur J Haematol Suppl; 1990; 52():29-31. PubMed ID: 2279542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia.
    Gastl G; Denz H; Abbrederis C; Huber H; Troppmair J; Wiegele J; Niederwieser D; Flener R; Huber C
    Onkologie; 1985 Jun; 8(3):143-4. PubMed ID: 3895095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.